Whats new
Whats new.
Petra Capital - Immutep Limited (IMM) - New clinical trial collaboration with Merck KGaA/Pfizer for Phase 1 with efti in urothelial cancer, a positive with more to come (Analyst: Tanushree Jain)
November 29th 2022
For a copy of this analyst report please contact your Petra advisor